Shantha, a Sanofi Company, began construction of an insulin manufacturing facility near Hyderabad, India, the company announced in a Jan. 29, 2015 press release. The facility is located in Muppireddipalli, in the state of Telangana, and will help address local and international demand. Sanofi�Original Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.